Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Source filing unavailable
Q4 2017 · —
Revenue$7.59B$7.59B+42.3% vs Q4 2016 Net Income-$828.00M-$828.00MN/M vs Q4 2016 EPS Diluted-$0.48-$0.48N/M vs Q4 2016 Gross Profit$3,747,000,000+29.2% Operating Incomederived$651,000,000−17.5% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,640,000,000+40.2% Free Cash Flowderived$1,295,000,000+52.2% Margins · derivedGross margin49.4%−5.0 pt vs Q4 2016
Operating margin8.6%−6.2 pt vs Q4 2016
Net margin-10.9%−25.9 pt vs Q4 2016